Results 151 to 160 of about 4,953 (183)
Some of the next articles are maybe not open access.

Pharmacotherapeutic follow-up in oncology

European Journal of Hospital Pharmacy, 2012
Background Morbidity and mortality associated with the use of medicines is a great problem of public health. The pharmacist has a key role in detection, preventing and resolving drug-related problems (DRP). This is even more important in the case of cancer patients, where the high number of treatment protocols and the extensive supportive therapy ...
P. Cavaco   +4 more
openaire   +1 more source

Can pharmacotherapeutic follow-up after allogeneic hematopoietic stem cell transplantation improve medication compliance?

Journal of Oncology Pharmacy Practice, 2022
Background Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) is currently one of the most effective therapies in onco-hematology. For the treatment of the disease and prevention of such complications, a complex pharmacotherapeutic regimen is employed. Non-compliance is prevalent among adolescents and young adults with chronic hematological
Maria Olívia Barboza Zanetti   +5 more
openaire   +2 more sources

Drug profile interactions and importance of multiprofessional pharmacotherapeutic follow-up of oncology outpatients.

Journal of Clinical Oncology, 2018
e18847Background: Drug interaction refers to the interference of one drug or nutrient in the action of another drug.
Nathalia Fonseca Gamboa   +10 more
openaire   +1 more source

Profile of indicators used in the implementation of pharmacotherapeutic follow-up services: a scope review.

2022
The pharmacotherapeutic follow-up service involves the analysis and understanding of the treatment of patients, aiming to promote a better quality of life and survival, with a holistic view of clinical and humanistic needs and treatment reduction.
de Almeida Amaral, Gustavo   +3 more
openaire   +1 more source

Cost effectiveness of pharmacotherapeutic follow-up in HIV-positive patients to improve immune response

European Journal of Hospital Pharmacy, 2012
Background Health costs are a global concern as the financial resources are limited. Identifying new practices that lead to economies in resources is a great challenge. Some studies have already indicated that pharmacotherapeutic follow-up (PFU) can decrease the costs, but more studies must be performed in this area to obtain more precise data ...
R.C. Carnevale   +6 more
openaire   +1 more source

[Evaluation of depressive symptoms and resilience in patients on pharmacotherapeutic follow-up].

Revista de calidad asistencial : organo de la Sociedad Espanola de Calidad Asistencial, 2018
This study aimed to carry out the pharmacotherapeutic follow-up of patients with depression and to assess its impact on the resilience of the patients. Patients were followed-up for 8 months. The pharmacist evaluated depressive symptoms, resilience, and the need for pharmaceutical intervention.
N C, Gomes   +4 more
openaire   +1 more source

Pharmacotherapeutic follow-up of opioid treated chronic pain patients within the Brazilian Unified Health System

Caderno Pedagógico
Chronic pain remains challenging, as complete pain control is poorly achieved with pharmacological and non-pharmacological intervention. Opioid analgesics are prescribed to minimize chronic pain; however, in addition to little evidence of long-term effectiveness, critical adverse effects such as dependence, tolerance, respiratory depression and others ...
Danielle Dias   +2 more
openaire   +1 more source

PHARMACOTHERAPEUTIC FOLLOW-UP BEFORE THE USE OF ANTITHROMBOTICS, ANTICOAGULANTS AND ANTIPLATETARYS: A REVIEW

International Journal of Health Science, 2022
Kleison Alves de Souza   +11 more
openaire   +1 more source

Home - About - Disclaimer - Privacy